Sadaga, Y., Watanabe, D., Najima, Y., Sadato, D., Hirama, C., Kato, K., . . . Doki, N. (2025). Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation. Taylor & Francis Group.
Chicago Style (17th ed.) CitationSadaga, Yasutaka, et al. Ponatinib/blinatumomab for Relapsed Philadelphia Chromosome-positive Leukemia as a Bridge to Allogeneic Transplantation. Taylor & Francis Group, 2025.
MLA (9th ed.) CitationSadaga, Yasutaka, et al. Ponatinib/blinatumomab for Relapsed Philadelphia Chromosome-positive Leukemia as a Bridge to Allogeneic Transplantation. Taylor & Francis Group, 2025.
Warning: These citations may not always be 100% accurate.